Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/56681

TitleEngineering nanoparticles for targeting rheumatoid arthritis: Past, present, and future trends
Author(s)Oliveira, Isabel Maria Lopes Matos
Gonçalves, C.
Reis, R. L.
Oliveira, J. M.
KeywordsDendrimers
Liposomes
Nanoparticles
Rheumatoid arthritis
Issue dateApr-2018
PublisherTsinghua University Press
JournalNano Research
CitationOliveira I. M., Gonçalves C., Reis R. L., Oliveira J. M. Engineering nanoparticles for targeting rheumatoidarthritis: Past, present, and future trends, Nano Research, Vol. 11, Issue 9, pp. 1-18, doi:10.1007/s12274-018-2071-3, 2018
Abstract(s)Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial joint inflammation and cartilage and bone tissue destruction. Although there exist some treatment strategies for RA, they are not completely safe and effective. Therefore, it is important to develop and test new drugs for RA that specifically target inflamed/swollen joints and simultaneously attenuate other possible damages to healthy tissues. Nanotechnology can be a good alternative to consider when envisioning precise medication for treating RA. Through the use of nanoparticles, it is possible to increase bioavailability and bioactivity of therapeutics and enable selective targeting to damaged joints. Herein, recent studies using nanoparticles for the treatment of RA, namely with liposomes, polymeric nanoparticles, dendrimers, and metallic nanoparticles, have been reviewed. These therapeutic strategies have shown great promise in improving the treatment over that by traditional drugs. The results of these studies confirm that feasibility of the use of nanoparticles is mainly due to their biocompatibility, low toxicity, controlled release, and selective drug delivery to inflamed tissues in animal RA models. Therefore, it is possible to claim that nanotechnology will, in the near future, play a crucial role in advanced treatments and patient-specific therapies for human diseases such as RA.
TypeArticle
URIhttp://hdl.handle.net/1822/56681
DOI10.1007/s12274-018-2071-3
ISSN1998-0124
Publisher versionhttps://link.springer.com/article/10.1007%2Fs12274-018-2071-3
Peer-Reviewedno
AccessOpen access
Appears in Collections:3B’s - Artigos em revistas/Papers in scientific journals

Files in This Item:
File Description SizeFormat 
19514-Oliveira_et_al-2018-Nano_Research.pdf1,53 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID